Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks - Test2 - elhamkhani - TriplyDB

Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks

Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks

http://www.wikidata.org/entity/Q24621546

about

Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility Fertility preservation in women with cervical, endometrial or ovarian cancers Fertility Preservation: A Key Survivorship Issue for Young Women with Cancer Genetics of the ovarian reserve BRCA Mutations, DNA Repair Deficiency, and Ovarian Aging Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair Controlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysis Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations Female infertility, infertility-associated diagnoses, and comorbidities: a review.BRCA1 and BRCA2 mutations and female fertility Ovarian response to controlled ovarian hyperstimulation in women with cancer is as expected according to an age-specific nomogram.Current state and controversies in fertility preservation in women with breast cancer.Absence of BRCA/FMR1 correlations in women with ovarian cancers Fertility preservation outcomes may differ by cancer diagnosis.Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer Diverse pathomechanisms leading to the breakdown of cellular estrogen surveillance and breast cancer development: new therapeutic strategies.Response to ovarian stimulation in patients facing gonadotoxic therapy.BRCA1/2 mutations appear embryo-lethal unless rescued by low (CGG n<26) FMR1 sub-genotypes: explanation for the "BRCA paradox"?Value of early referral to fertility preservation in young women with breast cancer.Fertility preservation and breast cancer: a review Ovarian stimulation in patients with breast cancer Initiation of puberty in mice following decellularized ovary transplant.Anti-Mullerian hormone and antral follicle count as predictors for embryo/oocyte cryopreservation cycle outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone.BRCA1 germline mutations may be associated with reduced ovarian reserve.Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise.Infertility etiologies are genetically and clinically linked with other diseases in single meta-diseases.Prospectively assessing risk for premature ovarian senescence in young females: a new paradigm.DNA stabilization by the upregulation of estrogen signaling in BRCA gene mutation carriers.BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk.Increased DNA damage and repair deficiency in granulosa cells are associated with ovarian aging in rhesus monkey.IVF for fertility preservation in breast cancer patients--efficacy and safety issues Determinants of access to fertility preservation in women with breast cancer.Fertility preservation in women with breast cancer Fertility preservation and pregnancy in women with and without BRCA mutation-positive breast cancer Effect of cancer on ovarian function in patients undergoing in vitro fertilization for fertility preservation: a reappraisal.Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond Baseline E(2) levels are higher in BRCA2 mutation carriers: a potential target for prevention?Comparison of age at natural menopause in BRCA1/2 mutation carriers with a non-clinic-based sample of women in northern California

P2860

Q24200437-7C81837B-BE9E-4230-A126-383C5D22A7A8 Q26741087-0FD3A557-173F-4109-86E9-C38951641E08 Q26747287-078529F0-0717-4AD2-8C27-9EE709DA8219 Q26777164-03196007-0ABE-4B85-8BC7-1EB1845AEF5E Q26801732-E873C69F-EDBB-47A9-B18C-ACB9D3FA8BF5 Q28267893-ED6A770F-0711-4F5E-ADA2-644925584863 Q28281796-A6FF524D-3739-4FE7-B1E5-5B381CE35DD1 Q28285540-4D1CD885-A132-4350-8382-637E658F1BB8 Q28392743-1304FA7F-9FE0-43BC-ADC8-6DB50F8B9412 Q30241736-45D150AC-7FAF-4F3C-BAFD-FE58D5FDB78E Q33567251-31852D76-54F5-4066-80F6-ACDDF9CE6BB3 Q33591882-656CCD47-6625-4BF1-AA2D-30DC926298A9 Q33779879-0D5C26CF-F3C5-48DA-8BA2-560881665220 Q33921477-0979D635-5012-4759-9D3D-2280DE10FCA0 Q34112999-E95B96A1-7D06-4BA8-B618-933E294D399E Q34152848-34CC034D-ACB3-4FF5-8426-53F2C6278B25 Q34198265-A34B2531-2929-41C9-A422-14A9E416959E Q34328177-548A3D3A-11B9-45D5-8AB5-6494D6BC226D Q34416088-D277BF03-B733-43B5-9E2A-EE44CDE6E2EC Q34577957-C1D99D86-4B24-491B-A80A-E13016D62950 Q35106163-AB399658-4603-4657-8D68-725AF872870A Q35106191-4DB5B4E8-FDD8-4474-8A72-B09FA6385899 Q35148516-C5C101E1-E7B4-4296-A19B-89D201BA1FB3 Q35181958-9BAF2CB4-14F9-493B-9143-166E7B2A12BF Q35213292-8754F7AA-FFD4-4780-A74F-1E964D1A8461 Q35236602-827F477D-FBE5-4EE5-8093-A84F9B26656E Q35254797-BC5B3E0B-C596-483B-B610-DA67965DB46E Q35503373-04112662-AD6D-4D32-A57D-21A4B73EED8F Q35532232-53BC9D68-1307-415A-A559-226117331997 Q35633272-BFDF25A0-36F9-4E37-9BED-D964A0814D60 Q35654355-84FFB1D0-06EC-499D-9388-0EF60B1AA001 Q35938140-BFD41C38-4F69-462C-BD13-C30981ACCF1A Q36010271-E4411B36-3D81-476B-A60A-81CA84427CB0 Q36060196-CCF03DAE-A881-4C05-A50A-2220038DA04D Q36115074-6071DC17-4893-467D-99A4-470EEF3C7CDB Q36405648-0EA31C0E-4B17-4338-9013-44369582E56D Q36568584-402764BF-35FC-47F3-8A6E-61B9924AB33E Q36619933-6A0A3F21-CD59-4744-97B1-5607478A64EA Q36642745-37AD3AEF-123A-4391-BB7D-0BF739F9B281 Q36791430-583EDF6E-D934-46E1-8A65-8066B4B91859

P2860

Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks

http://www.wikidata.org/entity/Q24621546

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Association of BRCA1 mutations ...... nd breast/ovarian cancer risks

@ast

Association of BRCA1 mutations ...... nd breast/ovarian cancer risks

@en

Association of BRCA1 mutations ...... nd breast/ovarian cancer risks

@nl

type

label

Association of BRCA1 mutations ...... nd breast/ovarian cancer risks

@ast

Association of BRCA1 mutations ...... nd breast/ovarian cancer risks

@en

Association of BRCA1 mutations ...... nd breast/ovarian cancer risks

@nl

prefLabel

Association of BRCA1 mutations ...... nd breast/ovarian cancer risks

@ast

Association of BRCA1 mutations ...... nd breast/ovarian cancer risks

@en

Association of BRCA1 mutations ...... nd breast/ovarian cancer risks

@nl

P1433

Q24621546-3E6ED322-FD8E-46D6-82C3-BCC736FC1069

P1476

Q24621546-9723198E-5409-4262-9CF5-169D831708A4

P2093

Q24621546-0045C307-AFB7-445D-9C04-E02A9490A8DA

Q24621546-4C927D07-F283-4D22-A8BD-7CD1BE65BAF3

Q24621546-6F17DDA7-AEAC-481D-B827-860FFC0DAC48

Q24621546-AC78C1FB-6874-4FD5-AA0F-1B62EACECA3C

P2860

Q24621546-08B381BC-E792-4EF5-97B2-6FAD1B3C697A

Q24621546-22F5A432-DC37-4DEA-BD46-F71CCBD7437D

Q24621546-24AF2689-E780-4EF7-9566-63A77B669EA7

Q24621546-2619A5D7-E623-42FF-BBD8-9200F3EB9AF6

Q24621546-388E2FFB-92E8-4A3D-8F53-DD84C46CD7D1

Q24621546-38F7429B-FB5F-49C6-B880-840FA63D1900

Q24621546-3ED4F0AE-2997-4FAC-AD64-C2A30C614841

Q24621546-5A980858-F5AA-4E8C-82C5-4ADE39851F86

Q24621546-622A147F-B362-4FC7-BA46-0E28DCE4D528

Q24621546-6D8BB9E2-A051-4A33-A300-768AFF96EACB

P304

Q24621546-4EDA6380-72A8-405D-A91A-B1A021999EC2

P31

Q24621546-EE07B46C-129E-44E7-B9C2-E6F4241FB24F

P3181

Q24621546-FAD1716C-9F7B-43AE-8D7D-1269113802BD

P356

Q24621546-6CC4087B-8B81-49E9-9195-99E472C95044

P407

Q24621546-B1F7F1A9-C5B8-41DE-94D8-B3336D4FA8C1

P433

Q24621546-866C4428-E045-4C93-A98F-8771418706B7

P478

Q24621546-A3554199-8F65-47E0-8A20-2D41908F2270

P577

Q24621546-5146A835-F270-4960-B72A-3EDD49C219A8

P698

Q24621546-FD2DE312-94BC-4916-A93E-E9F75C0A7E09

P921

Q24621546-AD1E2914-C042-4EA2-8F48-93A72F4C1924

P932

Q24621546-5599B647-D7BF-4A2A-8355-90F196CA211B

P3181

P356

JCO.2009.24.2057

P1433

Journal of Clinical Oncology

P1476

Association of BRCA1 mutations ...... nd breast/ovarian cancer risks

@en

P2093

David Barad

http://www.w3.org/2001/XMLSchema#string

Ja Yeon Kim

http://www.w3.org/2001/XMLSchema#string

Kutluk Oktay

http://www.w3.org/2001/XMLSchema#string

Samir N Babayev

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical practice. Primary ovarian insufficiency

Targeted disruption of exons 1 to 6 of the Fanconi Anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia

Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway

Cancer susceptibility and the functions of BRCA1 and BRCA2

Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation

BRCA2 deficiency in mice leads to meiotic impairment and infertility

ATR, BRCA1 and gammaH2AX localize to unsynapsed chromosomes at the pachytene stage in human oocytes

Growth retardation, DNA repair defects, and lack of spermatogenesis in BRCA1-deficient mice.

Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence.

Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization.

P304

240-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2103640

http://www.w3.org/2001/XMLSchema#string

P356

10.1200/JCO.2009.24.2057

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19996028

http://www.w3.org/2001/XMLSchema#string

P921

P932

3040011

http://www.w3.org/2001/XMLSchema#string